А new drug in the complex therapy of diabetes mellitus. Post-registration experience in patients with type 1 and type 2 diabetes mellitus
Diabetes mellitus (DM), due to its high incidence and prevalence, presents an urgent problem for the scientific community, which requires new ways of treating and preventing complications. Existing hypoglycemic treatment approaches do not always contribute to the achievement of glycaemic targets.Obj...
Main Authors: | S. V. Vorob'yev, E. U. Petrovskaya, N. A. Kuz'menko, I. A. Khripun |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2018-09-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2637 |
Similar Items
-
Significance of Hematological Parameters in Patients with Type-2 Diabetes Mellitus and Its Relationship with Disease Complications
by: Faraz Ali Rana, et al.
Published: (2023-02-01) -
A clinical study on musculoskeletal changes seen in type 2 diabetes mellitus: A single-center study
by: C A Jayashankar, et al.
Published: (2024-01-01) -
Evaluation of Chitotriosidase and Neopterin as Biomarkers of Microvascular Complications in Patients with Type 1 Diabetes Mellitus
by: Ancuța Cutaș, et al.
Published: (2021-02-01) -
Chronic kidney disease in patients with long-term type 1 diabetes mellitus
by: M. I. Yevloyeva, et al.
Published: (2023-12-01) -
Zebrafish: A Model to Study and Understand the Diabetic Nephropathy and Other Microvascular Complications of Type 2 Diabetes Mellitus
by: Charles Sharchil, et al.
Published: (2022-06-01)